4//SEC Filing
Bergenhem Nils 4
Accession 0001218893-11-000008
CIK 0001418919other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 3:05 PM ET
Size
9.8 KB
Accession
0001218893-11-000008
Insider Transaction Report
Form 4
Bergenhem Nils
Chief Scientific Officer
Transactions
- Disposition to Issuer
Common Stock
2011-04-05−13,875→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2011-04-05−17,500→ 0 totalExercise: $15.60Exp: 2020-02-01→ Common Stock (17,500 underlying) - Tax Payment
Common Stock
2011-04-05$27.25/sh−10,018$272,991→ 13,875 total - Exercise/Conversion
Common Stock
2011-04-05+17,500→ 23,893 total
Footnotes (3)
- [F1]17,500 options had an exercise price of $15.6000
- [F2]Pursuant to the Agreement and Plan of Merger between CPEX Pharmaceuticals, inc., FCB I Holdings Inc. and FCB I Acquisition Corp. dated January 3, 2011 (the "Merger Agreement"), each share of CPEX common stock was exchanged for $27.25. .
- [F3]This option is fully-vested.
Documents
Issuer
CPEX Pharmaceuticals, Inc.
CIK 0001418919
Entity typeother
Related Parties
1- filerCIK 0001480270
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 3:05 PM ET
- Size
- 9.8 KB